Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for bepirovirsen, an ...
New underwriting and appraisal assurance program eliminates most internal appraisal reviews while guaranteeing the quality of ...
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global ...
If all information is complete, the transaction will be processed in accordance with the published paperwork deadlines. You will receive an email confirmation once the request has been entered into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results